NYSE:CTEV - New York Stock Exchange, Inc. - US62548M2098 - Common Stock - Currency: USD
26.86
+1.83 (+7.31%)
The current stock price of CTEV is 26.86 USD. In the past month the price increased by 24.81%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.35 | 39.10B | ||
DOCS | DOXIMITY INC-CLASS A | 46.48 | 11.16B | ||
WAY | WAYSTAR HOLDING CORP | 50 | 6.83B | ||
CERT | CERTARA INC | 23.92 | 1.89B | ||
SDGR | SCHRODINGER INC | N/A | 1.76B | ||
PHR | PHREESIA INC | N/A | 1.54B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 12.56 | 1.53B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.29B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
EVH | EVOLENT HEALTH INC - A | 23.53 | 1.05B | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 837.09M | ||
HSTM | HEALTHSTREAM INC | 42.98 | 826.75M |
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
CLARITEV CORP
7900 Tysons One Place, Suite 400
McLean VIRGINIA US
Employees: 2700
Phone: 12127802000
The current stock price of CTEV is 26.86 USD. The price increased by 7.31% in the last trading session.
The exchange symbol of CLARITEV CORP is CTEV and it is listed on the New York Stock Exchange, Inc. exchange.
CTEV stock is listed on the New York Stock Exchange, Inc. exchange.
9 analysts have analysed CTEV and the average price target is 22.1 USD. This implies a price decrease of -17.72% is expected in the next year compared to the current price of 26.86. Check the CLARITEV CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CLARITEV CORP (CTEV) has a market capitalization of 449.37M USD. This makes CTEV a Small Cap stock.
CLARITEV CORP (CTEV) currently has 2700 employees.
CLARITEV CORP (CTEV) has a support level at 20.96. Check the full technical report for a detailed analysis of CTEV support and resistance levels.
The Revenue of CLARITEV CORP (CTEV) is expected to decline by -0.06% in the next year. Check the estimates tab for more information on the CTEV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CTEV does not pay a dividend.
CLARITEV CORP (CTEV) will report earnings on 2025-07-30.
CLARITEV CORP (CTEV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-71.82).
The outstanding short interest for CLARITEV CORP (CTEV) is 3.89% of its float. Check the ownership tab for more information on the CTEV short interest.
ChartMill assigns a technical rating of 5 / 10 to CTEV.
ChartMill assigns a fundamental rating of 2 / 10 to CTEV. Both the profitability and financial health of CTEV have multiple concerns.
Over the last trailing twelve months CTEV reported a non-GAAP Earnings per Share(EPS) of -71.82. The EPS decreased by -897.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -31.95% | ||
ROE | -1958.81% | ||
Debt/Equity | 53.67 |
ChartMill assigns a Buy % Consensus number of 78% to CTEV. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 85.54% and a revenue growth -0.06% for CTEV